Functional alterations in endocrine pancreas of rats with different degrees of dexamethasone-induced insulin resistance

Pancreas

Volumn 36, Issue 3, 2008, Pages 284-293

  Rafacho, Alex ^a   Giozzet, Vanessa A G ^a   Boschero, Antonio C ^a   Bosqueiro, José R ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Glucocorticoids; Glucose and insulin sensitivity; Insulin secretion; Pancreatic islets; Plasma lipids

Indexed keywords

CARBACHOL; DEXAMETHASONE; GLUCOSE; LEUCINE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; EX VIVO STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; IN VIVO STUDY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; DEXAMETHASONE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, NONESTERIFIED; GLUCOCORTICOIDS; GLUCOSE; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 41149165411     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31815ba826     Document Type: Article

References (42)

1. Nosadini R, Del Prato S, Tiengo A, et al. Insulin resistance in Cushing's syndrome. J Clin Endocrinol Metab. 1983;57:529-536.
2. Quddusi S, Browne P, Toivola B, et al. Cushing syndrome due to surreptitious glucocorticoid administration. Arch Intern Med. 1998;158:294-296.
3. Mora P. Post-transplantation diabetes mellitus. Am J Med Sci. 2005;329:86-94.
4. Holness MJ, Smith ND, Greenwood GK, et al. Interactive influences of peroxisome proliferator - activated receptor α activation and glucocorticoids on pancreatic beta cell compensation in insulin resistance induced by dietary saturated fat in the rat. Diabetologia. 2005;48:2062-2068.
5. Prada PO, Zecchin HG, Gasparetti AL, et al. Western diets modulate insulin signaling, c-Jun N-terminal activity, and insulin receptor substrate-1 phosphorylation in a tissue-specific fashion. Endocrinology. 2005;146:1576-1587.
6. Parsons JA, Brelje TC, Sorenson RL. Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology. 1992;130:1459-1466.
7. Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci. 1999;96:513-523.
8. Ogawa A, Jonson JH, Ohneda M, et al. Roles of insulin resistance and β-cell dysfunction in dexamethasone-induced diabetes. J Clin Invest. 1992;90:497-504.
9. Bonner-Weir S, Trent DF, Zamachinski CJ, et al. Limited beta cell regeneration in a beta cell deficient rat model: studies with dexamethasone. Metabolism. 1981;9:914-918.
10. Novelli M, De Tata V, Bombara M, et al. Insufficient adaptative capability of pancreatic endocrine function in dexamethasone-treated ageing rats. J Endocrinol. 1999;162:425-432.
11. Efendic S, Luft R, Wajngot A. Aspects of the pathogenesis of type 2 diabetes. Endocr Rev. 1984;5:395-410.
12. Toriumi C, Imai K. Altered expression of insulins I and II and their mRNAs in the islets of Langerhans in dexamethasone-induced diabetic rats. Biomed Chromatogr. 2003;17:26-32.
13. Ohneda M, Jonson JH, Inman L, et al. Glut-2 function in glucose-unresponsive β-cells of dexamethasone-induced diabetes in rats. J Clin Invest. 1993;92:1950-1956.
14. Gremlich S, Roduit R, Thorens B. Dexamethasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic B cells. Comparison with the effects of fatty acids. J Biol Chem. 1997;272:3216-3222.
15. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42:1663-1672.
16. Scott AM, Atwater I, Rojas E. A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans. Diabetologia. 1981;21:470-475.
17. Lo S, Russel JC, Taylor AW. Determination of glycogen in small tissue samples. J Appl Physiol. 1970;28:234-236.
18. Lacy PE, Kostianovsky M. Method for isolation of the intact islet of Langerhans from the rat pancreas. Diabetes. 1967;16:35-39.
19. Boschero AC, Delattre E, Santos ML. Isolamento de ilhotas de Langerhans de rato. Ribeirão Preto, SP: Anais XII Congresso Sociedade Brasileira Fisiologia; 1980:117.
20. Caldefie-Chezet F, Moinard C, Minet-Quinard R, et al. Dexamethasone treatment induces long-lasting hyperleptinemia and anorexia in old rats. Metabolism. 2001;50:1054-1058.
21. Mokuda O, Sakamoto Y, Ikeda T, et al. Sensitivity and responsiveness of glucose output to insulin in isolated perfused liver from dexamethasone treated rats. Horm Metab Res. 1991;23:53-55.
22. Ruzzin J, Wagman AS, Jensen J. Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signaling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia. 2005;48:2119-2130.
23. Wood SC, Lotter EC, McKay LD, et al. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature. 1979;282:503-505.
24. Torsoni MA, Carvalheira JB, Pereira-Da-Silva M, et al. Molecular and functional resistance to insulin in hypothalamus of rats exposed to cold. Am J Physiol Endocrinol Metab. 2003;285:E216-E223.
25. Palacios E, Piñon-López MJ, Racotta IS, et al. Effect of lipectomy and long-term dexamethasone on visceral fat and metabolic variables in rats. Metabolism. 1995;44:1631-1638.
26. Franco-Colin M, Tellez-Lopez AM, Quevedo-Corona L, et al. Effects of long-term high-sucrose and dexamethasone on fat depots, liver fat, and lipid fuel fluxes through the retroperitoneal adipose tissue splanchnic area in rats. Metabolism. 2000;49:1289-1294.
27. Bergman RN, Finegood DT, Kahn SE. The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest. 2002;32:35-45.
28. Davani B, Portwood N, Brysgalova G, et al. Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic β-cells develop diabetes. Diabetes. 2004;53:S51-S59.
29. Bagdade JD, Yee E Albers J, Pykalisto OJ. Glucocorticoids and triglycerides transport: effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat. Metabolism. 1976;25:533-542.
30. Slavin BG, Ong JM, Kern PA. Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. J Lipid Res. 1994;35:1535-1541.
31. Feldman D, Hirst M. Glucocorticoids and regulation of phosphoenolpyruvate carboxykinase activity in rat brown adipose tissue. Am J Physiol. 1978;235:E197-E202.
32. Barbera M, Fierabracci V, Novelli M, et al. Dexamethasone-induced insulin resistance and pancreatic adaptive response in aging rats are not modified by oral vanadyl sulfate treatment. Eur J Endocrinol. 2001;145:799-806.
33. Lee Y, Hirose H, Ohneda M, et al. Beta-cell lipotoxicity in the pathogenesis of non-insulin - dependent diabetes mellitus of obese rats: impairment in adipocyte - beta-cell relationships. Proc Natl Acad Sci U S A. 1994;91:10878-10882.
34. Milburn JL Jr, Hirose H, Lee YH, et al. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem. 1995;270:1295-1299.
35. McGarry JD, Dobbins RL. Fatty acids, lipotoxicity and insulin secretion. Diabetologia. 1999;42:128-138.
36. Nolan CJ, Leahy JL, Delghingaro-Augusto V, et al. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling. Diabetologia. 2006;49:2120-2130.
37. Blachier F, Leclercq-Meyer V, Marchand J, et al. Stimulus-secretion coupling of arginine-induced insulin release. Functional response of islets to L-arginine and L-ornithine. Biochim Biophys Acta. 1989;1013:144-151.
38. Gao Z0059, Gilon O, Henquin JC. The role of protein kinase-C in signal transduction through vasopressin and acetylcholine receptors in pancreatic B cells from normal mouse. Endocrinology. 1994;135:191-199.
39. Charles S, Tanagawa T, Henquin JC. A single mechanism for the stimulation of insulin release and 86 Rb+ efflux from rat islets by cationic amino acids. Biochem J. 1982;208:301-308.
40. Barg S. Mechanisms of exocytosis in insulin-secreting B-cells and glucagons A-cells. Pharmacol Toxicol. 2002;92:3-13.
41. Rorsman P, Renström E. Insulin granule dynamics in pancreatic beta cells. Diabetologia. 2003;46:1029-1045.
42. Rafacho A, Roma LP, Taboga SR, et al. Dexamethasone-induced insulin resistance is associated with increased connexins 36 mRNA and protein expression in pancreatic rat islets. Can J Physiol Pharmacol. 2007;53:881-885.